FindMyKOL
Clinical trialNCT02240628CompletedPhase 4Interventional

Combining Placing a Synera Patch With Propofol/Lidocaine Mixture to Decrease Pain With IV Propofol Injection

NCT02240628 is a phase 4 interventional trial sponsored by The University of Texas Health Science Center, Houston. As of 18 Nov 2026, it is completed. It studies Lidocaine and Saline in Pain on IV Injection of Propofol.. The registry lists an enrollment of 76 participants at 1 site in 1 country. The registry lists a start date of 31 Aug 2014 and a primary completion date of 30 Sept 2015.

SponsorThe University of Texas Health Science Center, HoustonEnrollment76Pain on IV Injection of Propofol.
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT02240628
FieldValue
Registry IDNCT02240628
StatusCompleted
PhasePhase 4
Study typeInterventional trial
Lead sponsorThe University of Texas Health Science Center, Houston
Enrollment76
Registered sites1
Countries1
ConditionsPain on IV Injection of Propofol.
DrugsLidocaine and Saline
Start31 Aug 2014
Primary completion30 Sept 2015
Study completion30 Sept 2015
Last update posted22 Jun 2016

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The main objective is to evaluate if combining placing the Synera patch and using Propofol /Lidocaine mixture will further decrease the pain associated with the IV injection of Propofol.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • samia khalil, M.D

    The University of Texas Health Science Center, Houston

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Texas, United States1 site
  • Memorial Hermann Hospital

    Houston

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexas: 1 siteTX1FloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Questions about NCT02240628

Each answer restates registry values shown on this page.

What is NCT02240628?

NCT02240628 is a phase 4 interventional trial sponsored by The University of Texas Health Science Center, Houston. It studies Lidocaine and Saline in Pain on IV Injection of Propofol..

Who leads NCT02240628?

The registry names samia khalil, M.D (principal investigator, The University of Texas Health Science Center, Houston) as the overall official.

Where does NCT02240628 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

Which drugs does NCT02240628 study?

The registered drug and biological interventions are Lidocaine and Saline.

When did NCT02240628 end?

The registry lists a primary completion date of 30 Sept 2015 and a study completion date of 30 Sept 2015. The sponsor last updated the record on 22 Jun 2016.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.